FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

80972005: Cefazolin sodium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2694484014 Cefazolin sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3499745013 Cefazolin sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3144441000005115 cephazolinnatrium da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cefazolin sodium Is a Product containing cefazolin (medicinal product) false Inferred relationship Some
Cefazolin sodium Is a Baktericid false Inferred relationship Some
Cefazolin sodium Is a Cefazolin false Inferred relationship Some
Cefazolin sodium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Cefazolin true Inferred relationship Some
Cefazolin sodium Is a First generation cephalosporin (substance) true Inferred relationship Some
Cefazolin sodium This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
cefazolin 20 g pulver til injektionsvæske, rekonstitution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cefazolin sodium Inferred relationship Some
cefazolin 250 mg pulver til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cefazolin sodium Inferred relationship Some
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cefazolin sodium Inferred relationship Some
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cefazolin sodium Inferred relationship Some
cefazolin 500 mg infusionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cefazolin sodium Inferred relationship Some
cefazolin 1 g infusionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cefazolin sodium Inferred relationship Some
cefazolin 10 g pulver til injektionsvæske, rekonstitution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cefazolin sodium Inferred relationship Some
cefazolin 5 g pulver til injektionsvæske, rekonstitution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cefazolin sodium Inferred relationship Some
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cefazolin sodium Inferred relationship Some 1
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cefazolin sodium Inferred relationship Some 1
Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cefazolin sodium Inferred relationship Some 1
Cefazolin (as cefazolin sodium) 10 g powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cefazolin sodium Inferred relationship Some 1
Cefazolin (as cefazolin sodium) 2 g powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cefazolin sodium Inferred relationship Some 1
Product containing precisely cefazolin (as cefazolin sodium) 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cefazolin sodium Inferred relationship Some 1
Product containing precisely cefazolin (as cefazolin sodium) 2 gram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cefazolin sodium Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start